STRYKER CORP
Latest Filing: May 11, 2026 • 25 Total Filings
Total Assets
2026
$46.29B
Total Revenue
2026
$6.02B
Net Income
2026
$745.00M
Operating Cash Flow
2026
$581.00M
Filing Year:
2024
Only 2024 data available
Data Source:
Showing data from all document types
Filters:
competes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
STRYKER CORP
Ticker: SYK
Penumbra, Inc.
Baxter International Inc.
Medtronic plc
Glucose monitoring devices, CGM systems, insulin pumps integrated with CGM
Major Competitor
Smith & Nephew
Advanced wound care market in MedSurg segment
Major Competitor
STERIS plc
Zimmer Biomet Holdings, Inc.
Instruments
Major Competitor
Johnson & Johnson MedTech
Instruments, Neurotechnology, and Orthopaedics
Major Competitor
ConMed Linvatec, Inc.
Instruments and Endoscopy
Major Competitor
Karl Storz GmbH & Co.
Endoscopy
Major Competitor
Olympus Optical Co. Ltd.
Endoscopy
Major Competitor
Smith & Nephew plc
Endoscopy and Orthopaedics
Major Competitor
Arthrex, Inc.
Endoscopy
Major Competitor
Zoll Medical Corporation
Medical
Major Competitor
Medline Industries
Medical
Major Competitor
Ferno-Washington, Inc.
Medical
Major Competitor
Terumo Corporation
Neurotechnology
Major Competitor
Zimmer
Joint replacement, trauma and extremities products, and robotics
Major Competitor
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor